Asian shares are mostly higher after China-US talks end without a trade deal
Beijing's top trade official said China and the United States agreed during two days of talks in Stockholm, Sweden, to work on extending an Aug. 12 deadline for imposing higher tariffs on each other. The U.S. side said an extension was discussed, but not decided on.
U.S. Trade Representative Jamieson Greer says the American team would head back to Washington and 'talk to the president about whether that's something that he wants to do.'
A Friday deadline is looming for many of Trump's proposed tariffs on other countries. Several highly anticipated economic reports are also on the way, including the latest monthly update on the job market.
'Markets had been floating on a cloud of trade optimism — first Japan, then the EU — but the sugar high is wearing off. Now, with U.S.-China talks dragging on in Stockholm, there's a growing sense that the momentum is stalling,' Stephen Innes of SPI Asset Management said in a commentary.
Hong Kong's Hang Seng index shed 0.3% to 25,441.64 while the Shanghai Composite index gained 0.5% to 3,628.53.
Tokyo's Nikkei 225 index edged less than 0.1% higher to 40,687.17. Gains for electronics companies were offset by losses for major exporters like Toyota Motor Corp. and Honda Motor Co.
Australia's S&P/ASX 200 climbed 0.6% to 8,759.20 and in South Korea, the Kospi gained 0.9% to 3,259.00.
Taiwan's Taiex rose 0.9% while the Sensex in India edged 0.1% higher.
On Tuesday, U.S. stock indexes edged back from their record levels as a busy week for Wall Street picked up momentum. The S&P 500 fell 0.3% to 6,370.86, while the Dow Jones Industrial Average lost 0.5% to 44,632.99.
The Nasdaq composite was down 0.4% at 21,098.29.
SoFi Technologies jumped 7.4%, but Merck dropped 2.2% and UPS sank 9.2% following a torrent of profit reports from big U.S. companies. They're among the hundreds of companies telling investors this week how much they made during the spring, including nearly a third of the stocks in the S&P 500 index.
UnitedHealth Group dropped 5.8% after reporting a profit for the spring that fell short of analysts' expectations. It also gave a forecast for profit over all of 2025 that investors found disappointing. The health care giant said it expected to earn at least $16 per share, when analysts were looking for something close to $20, according to FactSet.
Shares of Novo Nordisk that trade in the United States tumbled 21.3% after the Danish company cut its forecast for sales growth this year, in part because of lower expectations for its Wegovy weight-loss drug amid high competition.
Treasury yields sank as the Federal Reserve began a two-day meeting on interest rates.
Despite pressure from President Donald Trump for lower rates, which would give the economy a boost, the widespread expectation is that the Fed will wait for more data about how Trump's tariffs are affecting inflation and the economy before making its next move.
The U.S. economy appears to be slowing.
One report on Tuesday said that U.S. employers were advertising fewer job openings at the end of June than a month before, though still more than economists expected. A separate report said confidence rose among U.S. consumers, but a measure of their expectations about the near term remains below the level that typically signals a recession ahead.
In other dealings early Wednesday, U.S. benchmark crude oil picked up 7 cents to $69.28 per barrel, while Brent crude, the international standard, was up 13 cents at $71.82 per barrel.
The dollar fell to 148.13 Japanese yen from 148.48 yen. The euro rose to $1.1554 from $1.1546.
___
AP Business Writers Matt Ott and Stan Choe contributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
NeuroScientific Biopharmaceuticals (ASX:NSB) jumps 14% this week, though earnings growth is still tracking behind one-year shareholder returns
While some are satisfied with an index fund, active investors aim to find truly magnificent investments on the stock market. When you buy and hold the right company, the returns can make a huge difference to both you and your family. For example, the NeuroScientific Biopharmaceuticals Limited (ASX:NSB) share price is up a whopping 576% in the last 1 year, a handsome return in a single year. Also pleasing for shareholders was the 410% gain in the last three months. The longer term returns have not been as good, with the stock price only 6.4% higher than it was three years ago. We love happy stories like this one. The company should be really proud of that performance! On the back of a solid 7-day performance, let's check what role the company's fundamentals have played in driving long term shareholder returns. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During the last year NeuroScientific Biopharmaceuticals grew its earnings per share (EPS) by 54%. The share price gain of 576% certainly outpaced the EPS growth. So it's fair to assume the market has a higher opinion of the business than it a year ago. The fairly generous P/E ratio of 70.06 also points to this optimism. The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image). This free interactive report on NeuroScientific Biopharmaceuticals' earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. A Different Perspective We're pleased to report that NeuroScientific Biopharmaceuticals shareholders have received a total shareholder return of 576% over one year. That's better than the annualised return of 1.2% over half a decade, implying that the company is doing better recently. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 4 warning signs we've spotted with NeuroScientific Biopharmaceuticals (including 2 which are potentially serious) . For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
Trump: Aug. 1 tariff deadline ‘stands strong'
President Trump on Wednesday indicated there would be no extensions of the deadline at the end of the week, when steep tariffs are set to go into effect on many nations. 'The August first deadline is the August first deadline — It stands strong, and will not be extended. A big day for America!!!' Trump posted on Truth Social. Trump has issued letters to more than a dozen countries informing them of tariff rates they will face to export their goods into the United States beginning Aug. 1. Those include a 25 percent tariff on India, a 35 percent tariff on Bangladesh and a 50 percent tariff on Brazil, among others. The White House has struck deals with a handful of other countries to set lower tariff rates, including with Japan, the European Union, Indonesia and the United Kingdom. Critics have argued the details around those agreements are still scarce and have noted that the tariff rate those countries will pay, while lower than an initial threat, is still higher than it was before Trump took office. The timing and severity of tariffs on other nations have been shifting targets since Trump took office, after he vowed on the campaign trail to aggressively impose duties on imports. He has repeatedly threatened tariffs on other nations, only to back off or delay their imposition. The president on April 2 announced 'reciprocal' tariffs on dozens of other countries, using trade deficits to help calculate the tariff rate. But a week later, he lowered those rates to 10 percent for 90 days as markets reacted negatively, giving time for negotiations. The 90-day window was set to expire in early July, only for Trump to set a new deadline of Aug. 1. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword
Yahoo
35 minutes ago
- Yahoo
Lutnick says tariffs set in place Aug 1: ‘No extensions. No more grace periods.'
Commerce Secretary Howard Lutnick said on Sunday that President Trump would not grant any further extensions to countries wishing to negotiate trade deals ahead of the Aug. 1 deadline. 'No extensions, no more grace periods. Aug. 1, the tariffs are set,' Lutnick said in an interview on 'Fox News Sunday.' 'They'll go into place, customs will start collecting the money, and off we go,' Lutnick continued. Lutnick added, however, that the president would be open to continuing to negotiate even once the tariffs are in place. 'Obviously after Aug. 1, people can still talk to President Trump,' Lutnick said. 'I mean, he's always willing to listen.' The president will also continue to talk to other countries before the Aug. 1 deadline, Lutnick added. 'Whether they can make him happy is another question,' Lutnick said. 'But the president's definitely willing to negotiate and talk to the big economies for sure.' The interview came shortly before Trump announced a trade deal with the European Union, setting tariffs at 15 percent for European goods, including automobiles. The EU agreed to purchase $750 billion worth of energy from the U.S. as part of the deal, Trump announced on Sunday, and to invest in the U.S. $600 billion more than the current investments for other goods. The agreement is lower than the 30 percent tariff Trump had threatened to impose on the EU, which was set to take effect on Aug. 1, and avoids a trade war with the U.S.'s largest trading partner. Trump earlier this month posted letters to social media sent to more than a dozen countries vowing to impose steep tariffs on their imports starting Aug. 1. An initial round of tariffs unveiled in April was paused for 90 days to allow time for negotiations, and the president then pushed the deadline for the tariffs to take effect back by another few weeks — to Aug. 1. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword